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Abstract
Background: Despite the increasing incidence of laryngeal squamous cell carcinoma (LSCC) in Algeria, scarce
information is available on the importance of the preventable etiological factors which may drive the disease.
Remarkably, a significant number of cases occur in nonsmoker and nondrinker patients; hence, suggesting
that alternative risk factors, like Human papillomavirus (HPV), might be etiologically involved. To gain more
insight on the risk factors associated with the disease in the country, we evaluated the etiological fraction
of HPV in comparison to tobacco and alcohol intake in LSCC patients.
Methods: To evaluate the etiopathologic fraction (EF) for HPV compared to history of tobacco and alcohol in
LSCC, HPV DNA presence in 46 invasive and 3 non-invasive formalin-fixed paraffin-embedded laryngeal tumors
was screened using the SPF10-DEIA-LiPA25 Assay. Demographic data and information related to exposure to
the risk factors were gathered through interviewer-assisted questionnaires.
Results: We observed that 40.8% of all LSCC cases were associated with smoking, 40.8% had combined tobacco and
alcohol exposure history, and 14.3% did not show prior exposure to either risk factor. 1 out of 3 in-situ carcinoma cases
was positive for HPV-6. HPV prevalence was null in the invasive tumors. HPV DNA was detected in 2.38% for all studied
cases. 10.2% of LSCC patients did not associate with any of the studied risk factors.
Conclusion: Here we show that HPV etiological fraction in LSCC Algerian patients is low and smoking and alcohol
remain the principal etiopathologic risk for LSCC burden in Algeria.
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Background
Laryngeal cancer (LC) is the most common head and
neck cancer (HNC). It accounted for 1.6% of all new
cancer cases and 1.1% of deaths in 2012 worldwide [1].
The major histopathological form of these cancers con-
sists of 95–98% laryngeal squamous cell carcinomas
(LSCC) [2]. LSCC is a highly metastatic tumor, for which
the 5-year survival rate at 10 years does not exceed 50%
for stage IV [3]. The condition occurs principally
between the fifth and the seventh decade of life and af-
fects predominantly males (sex ratio 5:1 to 30:1) [4]. In
Algeria, LSCC prevalence in men has significantly
increased from 4.4% in 2009 to 5.6% in 2012, and the
trend for the years to come predicts a steady increase to
reach 6.3% by 2020; thereby reaching a 300% increase
since 1986. Similarly, LSCC incidence increased from 1.7
to 6.4 per 105 inhabitants between 1986 and 2010 [5, 6].
Considering the increasing impact of the disease on the
Algerian population, it became important that improved
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knowledge on the exposure to the preventable risk fac-
tors of LSCC is acquired to ameliorate health policies
and reduce the disease associated mortality.
Tobacco and alcohol are the main risk factors for
LSCC. Both act as powerful forces driving epigenetic
reprogramming and genetic instability to induce onco-
genesis [4, 7, 8]. Tobacco has been incriminated as the
most important risk factor for the development of the
disease, with a relative risk varying from 1.5 to 9-fold
[9]. Alcohol regular intake has been also implicated as
an independent risk factor, and found to increase dis-
ease’s risk by 2 to 5-fold [10, 11]. Importantly, the com-
bined effect of tobacco and alcohol has been shown to
exceed the sum of the individual risks, with odds ratio
reaching 177 for heavy drinkers and heavy smokers [11].
In Algeria, smoking and alcohol dependence have been
lately notably higher in men compared to women (re-
spectively, 27.1% vs. 1.7% in 2016; 1.4% vs. < 0.1 in
2010) and current reports have indicated an increase
trend for tobacco and alcohol consumption in the
country [12, 13]. Despite these numbers, no previous
publication has ever evaluated the importance of
these risk factors in LSCC patients.
Interestingly, approximately 5% of all LSCC showed
to happen in nonsmoker and nondrinker patients,
thus suggesting that alternative carcinogenic factors
may induce LC [14]. In the last decade, human papil-
lomavirus (HPV) infections have been associated with
22.1% of head and neck squamous cell carcinomas
(HNSCC) [15] and have been related to 15–20% of
those occurring in nonsmoking and nondrinking pa-
tients [16]. Marked differences in HPV attributable
fraction in oral tumors have been shown to prevail
between different populations and geographical re-
gions [17–21]; these variations being due to heteroge-
neous testing procedures taking principally into
account different number of biomarkers [15, 22].
Consequently, the previously over estimation of HPV
associated fraction in the larynx, has been recently
reevaluated to lower figures varying between 1.5% and
5.7%, depending on the biomarkers used (HPV DNA/
mRNA/p16INK4a) [15, 17, 18]. To date, limited infor-
mation is available on HPV burden in HNSCC in
Algeria, and most of the available information on
HPV infections is limited to cervical cancer, for which
the prevalence for the general population has been
estimate at 6.3% [23]. To the best of our knowledge,
only a small cohort limited to 5 laryngeal tumors has
been screened for HPV DNA, and for which, intri-
guingly, a null prevalence was reported [24].
To gain more insight on the prevalence of HPV infec-
tion in LSCC Algerian patients, a strict standardized
protocol was applied to assess the etiological fraction of
HPV compared to tobacco and alcohol in Algeria.
Methods
Specimen preparation
Tumors specimens were prospectively obtained from 58
patients, admitted between 2012 and 2016 at the Oto-
laryngology department of Algiers University Hospital
Mustapha Pacha, upon informed consent. Cases were
randomly recruited during two days per week; biopsies
were performed on patients presenting a radiological re-
port in favor of a laryngeal tumor, and fragments were
used for the present study. The specimens were immedi-
ately fixed in formol (10%). Following fixation, the biop-
sies were rinsed twice in phosphate-buffered saline
(PBS) and then manually dehydrated in ascending series
of ethanol solutions (80%–100%, 1H). The samples were
then cleared in xylene and embedded in paraffin.
Demographic (age, gender) and risk factors data (to-
bacco, alcohol and oral sexual practices) were gathered
for the purpose of this study through an interviewer-
assisted questionnaire led by the treating physician. This
study was approved by the ethics committee of the
Algerian National Agency for Research and Develop-
ment in Health (ATRSS).
Histopathological evaluation
The histopathological evaluation was performed for all
collected specimens by expert pathologists based on the
conventional classification of the world health
organization (WHO). The type of infiltration and degree
of differentiation of the tumors was evaluated, and the
presence of HPV cytopathic effect (koilocytosis) was
verified. Specimens with epithelial tumor in hematoxylin
and eosin (HE)-stained sections were kept for analysis.
HPV-DNA detection and genotyping
A sandwich sectioning method was used to prepare
paraffin sections for HPV screening protocol as previ-
ously described [25]. In brief, four paraffin sections were
obtained for each block. The outer sections served to
confirm the histological diagnosis and the inner ones
served for HPV detection. The microtome was cleaned
after each sample sectioning and the blade was changed
between the cuttings of each block. Gloves were regu-
larly changed and blank paraffin block was systematically
sectioned after each block to ensure no possibility of
HPV DNA carryover between sectioning samples.
Paraffin sections of histologically confirmed cases were
used to extract DNA. 250 μl of freshly prepared protein-
ase K solution (pH 8.0) was added directly to the paraf-
fin sections and incubated at 70 °C until full digestion of
the tissues. After proteinase K heat inactivation, HPV
DNA detection was performed using SPF10-DEIA-
LiPA25 version 1 system (Labo BiomedicalProducts,
Netherlands). In brief, a 65-bp fragment of the L1 open
reading frame of HPV was amplified employing the
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SPF10 consensus primers. Presence of HPV DNA was
determined by DNA enzyme immunoassay (DEIA) using
10 μl of the amplified product that was hybridized to a
mixture of conservative probes recognizing at least 54
HPV genotypes. Optical densities were read at 450 nm,
and samples were categorized as HPV DNA negative,
positive or borderline. Positive amplimers were geno-
typed using reverse hybridization line (LiPA25) that de-
tects 25 high and low-risk HPV types (6, 11, 16, 18, 31,
33, 34, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58,
59, 66, 68, 70, and 74). Results were interpreted follow-
ing manufacturer’s instructions. DNA quality of the sam-
ples was assessed by amplification of human tubulin
gene with a specific set of primers. DEIA negative and
tubulin positive samples were considered negative for
HPV, while DEIA negative and tubulin negative samples
were excluded from the HPV analysis.
Statistical analyses
Statistical analyses were performed using GraphPad
Prism software version 6.0.1. The Chi-square test was
used to analyze the differences in proportion. p-values
≤0.05 were considered statistically significant.
Results
Description of the demographic and clinical
characteristics of the studied cases
A total of fifty-eight cases of LC were prospectively ob-
tained for analysis. Of these, nine were excluded after
histological evaluation for absence of tumor tissue.
Demographic and clinical description of the forty-nine eva-
luable cases is summarized in Table 1. The median age of
the patients at the time of diagnosis was 66 years (range:
37–87). The male to female ratio was equal to 8.8:1.
Of the 49 tumors, 29 (59.2%) were located in the glot-
tis and two (4.1%) were located in the epiglottis. Tumors
invading glottis and epiglottis or glottis and subraglottic
areas were identified in 13 (26.5%) and two (4.1%) cases
respectively. Three patients (6.1%) had tumors invading
the three laryngeal regions. The majority of cases
(93.9%) were diagnosed at invasive stage and only three
tumors (6.1%) were in-situ carcinoma histological grade.
Conventional type squamous cell carcinoma was the
predominant histological type (87.8%).
HPV etiologic fraction among LSCC is low
To screen for presence of HPV DNA, our samples were
tested following the procedure outlined in Fig. 1. Insuffi-
cient DNA quality hampered HPV status analysis in
seven invasive LSCC cases. Strikingly we observed that
none of the remaining 39 analyzed invasive tumors showed
to contain HPV DNA. Conversely, among the three diag-
nosed in-situ carcinoma cases, HPV DNA was detected
only in one; therefore resulting in a prevalence of 2.38% (1/
42 cases). Subsequent genotyping identified it as HPV6,
(Fig. 1). Thus, HPV prevalence showed to be null among
invasive LSCC, while concerning one in-situ carcinoma.
Tobacco consumption alone or in conjunction with
alcohol constitutes the major EF associating with LSCC
To compare the etiopathologic fraction (EF) due to HPV
with those due to the classical risk factors of LSCC, in-
formation on oral sex practice, tobacco, alcohol intake
and HPV presence were confronted for each patient
(Fig. 2). Patients’ stratification showed that 42 of them
(85.7%) endorsed a history of smoking and 20 (40.8%) of
alcohol exposure. Of these, respectively, 95.2% and 95%,
presented invasive tumors. The combined rate of alcohol
and tobacco exposure was 40.8%. Women declared
themselves to be exposed only to second hand smoking,
and thus only 7 patients (14.3%) fall into the nonsmoker-
nondrinker category (Fig. 2). Patients’ stratification in
function of the risk factors showed that 40.8% of LSCC
cases would be due to tobacco alone and that alcohol
intake was strictly associated with tobacco exposure.
To evaluate the burden of the risk factors in the stud-
ied patients, tobacco units were defined as number of
cigarettes/day; alcohol exposure was defined according
to the frequency of drinks per week, and risk factors ex-
posure was stratified based on the gender (Fig. 3).
Among male patients, 70.45% were heavy smokers (> 20
cigarettes/day) and 25% were moderate smokers (≤20
cigarettes/day). Males endorsed a frequent alcohol con-
sumption in 29.5% of cases and occasional in 15.9%.
Therefore, our data show that tobacco consumption
Table 1 Descriptive characteristics of the patients. Demographic
and clinical data









Glottis/ Sub-glottis 2 (4.1)
Epiglottis/Glottis/Sub-glottis 3 (6.1)
Histological grade
Carcinoma in situ 3 (6.1)
Invasive carcinoma 47(93.9)
- Conventional SCC 43(87.8)
- Basaloid 3 (6.1)
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alone or combined with alcohol would constitute the
highest etiologic fractions of LSCC in males.
HPV prevalence in nonsmoker and nondrinker patients
As HPV related HNC has been described to be likely
diagnosed in young, nonsmoker/nondrinker patients
practicing oral sex [22], we next analyzed the profile of
association existing between HPV status, oral sex prac-
tice, patient’s age and the smoking/drinking profile.
The single positive low risk HPV case was found in a
nonsmoker-nondrinker woman aged 59, with no history
of oral sex practice (Fig. 2). This result led to an ob-
served significant difference in HPV status between
women and men (p = 0.005) (Fig. 3D). We concluded
then, that the etiopathologic fraction of HPV among
nonsmokers and nondrinkers would equal 14.28% (1/7
cases) in the cohort and 20% among women.
Because oral sex practice may favor HPV transmis-
sion from infected women genitals to men upper
aero-digestive tract and lead to oropharyngeal car-
cinogenesis in nonsmoking male partners [26], and as
the prevalence of genital HPV in Algerian women
reaches 6.3% [23], we extended our analysis to a pos-
sible association between LSCC risk factors and HPV
for the 3 patients which reported having oral sexual
activities (4.54% of men and 20% of women, p = 0.17)
(Fig. 3E). Surprisingly, as no such associations were
observed, we found that 10.2% of the patients (5/49
cases) did not associate with any of the studied risk
factors. This result suggested that additional risk
factors could be involved in LSCC etiology.
Fig. 1 Chart of the work flow followed for the detection of HPV DNA in LSCC. The chart depicts the disposition of LC samples processing.
DEIA-LiPA assay was performed to test for HPV DNA in 49 tumors. The tubulin gene was used as internal control
Fig. 2 Individual histological and EF characteristics of the studied LSCC patients. The chart shows a stratification of the patients following ICO
diagnosis, DEIA-LiPA assay results, and patients’ data gathered through interviewer-assisted questionnaires. N.E: Not Evaluable
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Discussion
Similarly to the rest of the world, Algeria has witnessed dur-
ing the last 30 years a dramatic increase in LSCC incidence
rate [5]. This epidemiologic transition prompted the scien-
tific community to investigate its preventable causes, and to
explore HPV as an emerging alternative risk factor of oral
carcinogenesis. Contrarily to oropharyngeal carcinoma, the
role of the virus in LC remains to date intriguing, particu-
larly when considering the various meta-analyses which have
estimated the prevalence of HPV in LC [25] and its fre-
quency in nonsmoking and nondrinking LC patients [16].
Despite the global interest for the association, no prior study
has ever conducted a comparative assessment of HPV, to-
bacco and alcohol as risk factors of LSCC in the country.
Here, we estimated the EF for HPV in LSCC at 2.38%.
Our observation is in agreement with the most recent eval-
uations which showed that the EF for HPV in LC is gener-
ally low in comparison to other HNC sites [15, 17].
Interestingly, this finding places Algeria, among the coun-
tries where LC would be the less affected by HPV infections
[18, 25]. Indeed, several authors have described higher HPV
prevalence for Latin-America compared with Western-
Africa, Southern-Europe, USA and Southwestern-Asia [17,
19–21]. When taking into account the impact that the
screening techniques may exert on HPV detection [17, 19,
25], we observed that HPV prevalence in Algeria was infer-
ior to that described for the larynx in the world [17, 18]. At
the opposite, it showed to be superior to that found in India
(1.7%) [27]. These differences would likely result from the
possible influence that the age, the genetics and the envir-
onment of a patients may exert on viral transmission and
persistence in an infected tissue [25, 28]. Therefore, it is
possible that the advanced age of our study group may have
constituted a possible limit to HPV detection, in particular
considering that HPV would likely be diagnosed in younger
adults under the age of 50 [28–30]. Another reason for the
low HPV prevalence in our cohort, would probably be due
to the low frequency of oral sex practice among aged
patients, and especially among males, which have shown by
others to carry the highest risk of oral infection [31].
Exploring the differences in oral sex practice in men, might
clarify the observed differences. By contrast, we observed a
higher prevalence of oral sex practice and HPV infection
among women.
Fig. 3 Risk factor exposure assessment by gender. Tobacco units were defined as number of cigarettes/day and alcohol exposure according to
the frequency of drinks/week, HPV status was evaluated as previously described. Proportions were calculated among women (n = 5) and men
(n = 44) and the χ2-test was used to analyze differences in proportion. p values ≤0.05 were accepted as statistically significant. N.E: Not Evaluable.
Profiles by gender (expressed in percentage) of a) Cigarette consumption per day, b) Alcohol frequency consumption, c) Combined tobacco-
alcohol consumption, d) HPV screening test result and e) Oral sex practice.
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Considering our observation, that the single HPV-LC
positive case was found in a women, the recent demon-
strations that oral HPV would be frequently detected in
patients with HPV cervical lesions [32], and the important
rate of genital HPV infections in female in Algeria [23], it
is important that next studies focus on determining the
rate of association existing between cervical HPV lesions
and HPV prevalence in LSCC patients. Also, future explo-
rations should focus on male partners of women with
HPV cervical lesions, as they may have a significantly
greater incident rate of HPV related HNC [28, 33]. There-
fore, we believe that a focus should be put next, in particu-
lar, on examining the prevalence of HPV infections among
sexual partners for which females have been diagnosed
with HPV infection(s), and consider their follow-up to
evaluate the HPV related risk of carcinogenesis.
In this study, we also observed that, while among the
invasive LSCC cases HPV prevalence was null, 1 out of
3 in-situ carcinoma cases were positive for HPV6. These
findings are in agreement with reports from Castellsague
et al. (2016), which described HPV6 as figuring among
the most frequently detected HPV genotypes associating
with LC [17]. It is noteworthy that Villagómez-Ortíz and
al. (2016) proposed that HPV infections would tend to
be diagnosed at early stages of LSCC progression, in par-
ticular among laryngeal papillomatosis (LP) with severe
dysplasia cases [29]. LP is a benign tumor, frequently as-
sociating with HPV6 or HPV11, which shifts in 1–4%
cases towards malignancy [34]. Despite this association,
several studies pointed out that HPV DNA positivity in
LC would not prove the viral oncogenicity, as it may
only be coincidental with a transient infection which
happens also to occur in 11.2% normal laryngeal tissues
[35]. Therefore, complementary screenings including
amplification of the viral E6 transcript and interrogation
of the specific genetic alterations induced by HPV infec-
tion should be conducted to conclude on the carcino-
genic aspect of the viral infection [36, 37].
Our observation that LSCC occurs in absence of HPV,
enforces the idea that tobacco and alcohol may be cen-
tral to laryngeal carcinogenesis. Indeed, from a total of
49 patients, 85.7% were active smokers, 40.8% were alco-
hol drinkers and 40.8% had a mixed profile. Considering
the heavy frequency of smoking (> 20 cigarettes/day)
observed in our patients, the exposure to tobacco seems
to constitute the principal cause of the disease. This idea
is further supported by the reports indicating a wider ac-
cess to tobacco in the society over alcohol, as indicated
by the recent estimates indicating that 25.3% of men,
0.3% of women and 18% of boys would daily use tobacco
[38] and WHO data reporting a total alcohol consump-
tion per Algerian capita (> 15 years of age) under 2.5 L
of pure alcohol in 2015 [39]. From the analysis of the
risk factors associating with the nonsmoker/nondrinker
profile, we observed a low prevalence of the viral
etiology (14.28%). Due to rarity of both events, this
number should be confirmed on a much larger cohort
also including younger patients. Indeed, substantial find-
ings have indicated that HPV-induced HNC would ra-
ther occur in younger patients with frequent oral sex
practice [22]. Thus, considering the possible behavioral
changes that may occur in the population, we suggest to
keep on evaluating the risk factors implicated in LSCC.
By contrast to the literature, we found that 10.2% of
the tumors occurred in patients showing no prior expos-
ure to any of the studied risk factors; this observation
exceeded by two folds the generally observed rates [14].
Hence, we hypothesize that unexplored factors may par-
ticularly contribute to LSCC development in Algeria. To
get a better insight on the matter, future studies should
explore, in priority exposure to second-hand smoking
and to the known dietary and environmental carcino-
gens like salt-preserved food and coal dust for their like-
lihood to increase the risk of LSCC [40–42]. As well as,
endogenous factors like gastroesophageal reflux disease
which could act as a promoting factor in the malignant
transformation of the normal mucosal surface of the lar-
ynx [43]. Exploring the recently discovered gene variants
of susceptibility to the condition, like in Mdm2 (Mouse
double minute 2) and BCL11 (B-cell lymphoma), and
those incriminated specifically to have no interaction
with drinking and smoking, in HLA (human leukocyte
antigen) region 6p21, FADS1 gene (fatty acid desaturase
1) and tumor suppressor TBX5 (T-box 5) genes, should
be analyzed to quantify the inherited risk to develop
LSCC in nondrinkers and nonsmokers, and provide a
rational ground to anticipate and prevent the disease in
the population [44–46].
Conclusion
In summary, our data suggest that HPV infection would
have little impact on the development of LSCC, while to-
bacco and alcohol, would represent its major preventable
risk factors. Considering the growing accessibility to to-
bacco and alcohol for the youngest, it is probable that the
disease burden will remain high for the next decades in
the country. Although our findings need to be confronted
to larger case series, they constitute, to the best of our
knowledge, the first rational arguments for the national
health authorities to consider policies to reduce tobacco
and alcohol consumption to decrease LSCC prevalence in
Algeria and warrant the evaluation of the inherited risk to
develop LSCC in the general population.
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